Michelle A Lowes Selected Research

Biological Therapy

1/2022	Biologic therapy is not associated with increased COVID-19 severity in patients with hidradenitis suppurativa: Initial findings from the Global Hidradenitis Suppurativa COVID-19 Registry.
3/2021	Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?
6/2007	Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis.
2/2007	Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series.
8/2005	Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michelle A Lowes Research Topics

Disease

42	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2018 - 10/2004
13	Hidradenitis Suppurativa 01/2022 - 01/2018
9	Inflammation (Inflammations) 01/2018 - 08/2005
6	Skin Diseases (Skin Disease) 01/2020 - 02/2005
3	Neoplasms (Cancer) 12/2013 - 10/2007
3	Autoimmune Diseases (Autoimmune Disease) 02/2008 - 10/2004
2	Anemia 01/2022 - 09/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 06/2017 - 12/2013
2	Atopic Dermatitis (Atopic Eczema) 01/2016 - 11/2008
2	Hyperplasia 04/2013 - 07/2006
1	Chronic Disease (Chronic Diseases) 01/2022
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2022
1	COVID-19 01/2022
1	Pain (Aches) 07/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2021
1	Pemphigus (Pemphigus Vulgaris) 01/2020
1	Angioedema 01/2020
1	Bullous Pemphigoid (Pemphigoid) 01/2020
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Vitamin D Deficiency 01/2017
1	Peanut Hypersensitivity (Peanut Allergy) 11/2016
1	Necrosis 03/2013
1	Cryopyrin-Associated Periodic Syndromes 01/2012
1	Atherosclerosis 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2012
1	Fibrosarcoma 02/2010
1	Rheumatoid Arthritis 11/2009
1	Sepsis (Septicemia) 11/2009
1	Crohn Disease (Crohn's Disease) 11/2009

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 01/2018 - 10/2004
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2021 - 12/2005
8	Interleukin-17 (Interleukin 17)IBA 11/2016 - 05/2008
6	efalizumab (Raptiva)FDA Link 01/2012 - 10/2004
5	Etanercept (Enbrel)FDA Link 01/2018 - 08/2005
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 12/2007
5	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 10/2010 - 12/2005
5	Alefacept (Amevive)FDA Link 02/2010 - 02/2005
4	Biological ProductsIBA 03/2021 - 12/2007
4	Interleukin-8 (Interleukin 8)IBA 01/2014 - 08/2005
4	ChemokinesIBA 01/2014 - 05/2007
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2007
3	Pharmaceutical PreparationsIBA 03/2021 - 11/2009
3	LigandsIBA 01/2018 - 05/2007
3	Interleukin-1 (Interleukin 1)IBA 04/2013 - 08/2005
2	Adalimumab (Humira)FDA Link 03/2021 - 03/2021
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2018
2	Blood Proteins (Serum Proteins)IBA 01/2018 - 01/2014
2	AntigensIBA 07/2013 - 08/2008
2	Interleukin-23 (Interleukin 23)IBA 04/2013 - 11/2008
2	TNF-Related Apoptosis-Inducing LigandIBA 03/2013 - 06/2010
2	NF-kappa B (NF-kB)IBA 05/2012 - 05/2012
2	Interleukin-12 (IL 12)IBA 10/2010 - 10/2007
2	HLA-DR Antigens (HLA-DR)IBA 10/2010 - 10/2009
2	Messenger RNA (mRNA)IBA 11/2008 - 05/2008
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 05/2008 - 02/2008
1	HepcidinsIBA 01/2022
1	Infliximab (Remicade)FDA Link 03/2021
1	Hemoglobins (Hemoglobin)IBA 09/2019
1	hemoglobin ASIBA 09/2019
1	C-Reactive ProteinIBA 09/2019
1	Indicators and Reagents (Reagents)IBA 09/2019
1	tofacitinibIBA 01/2018
1	ProteomeIBA 01/2018
1	RNA (Ribonucleic Acid)IBA 06/2017
1	Staphylococcal Protein A (Protein A)IBA 06/2017
1	Cholecalciferol (Vitamin D3)FDA Link 01/2017
1	25-hydroxyvitamin DIBA 01/2017
1	hydroxide ionIBA 01/2017
1	LipidsIBA 01/2017
1	Immunoglobulin E (IgE)IBA 11/2016
1	Isotretinoin (Accutane)FDA LinkGeneric 11/2016
1	EnzymesIBA 01/2016
1	kynureninaseIBA 01/2016
1	Tryptophan (L-Tryptophan)FDA Link 01/2016
1	fontolizumabIBA 02/2015
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2015
1	MitogensIBA 12/2013
1	InterleukinsIBA 04/2013
1	Tumor Biomarkers (Tumor Markers)IBA 03/2013
1	DNA (Deoxyribonucleic Acid)IBA 05/2012
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2012
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2012
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2012
1	Lysosomal-Associated Membrane Protein 2IBA 10/2010
1	Interleukin-23 Subunit p19IBA 10/2010
1	Chemokine CCL5IBA 02/2010
1	ChloridesIBA 02/2010
1	Tumor Necrosis Factor InhibitorsIBA 11/2009

Therapy/Procedure

12	Therapeutics 12/2020 - 08/2005
5	Biological Therapy 01/2022 - 08/2005
2	Pain Management 07/2021 - 01/2021
1	Analgesia 07/2021
1	Lasers (Laser) 01/2021
1	Complementary Therapies (Alternative Medicine) 01/2021
1	Intradermal Injections 04/2012
1	Aftercare (After-Treatment) 01/2012
1	Radiotherapy 11/2010
1	Precision Medicine 02/2010